Login to Pancreatic Cancer UK

Clinical Pioneer Awards

Clinical Pioneer Awards Web Banner Plus Text

Pancreatic Cancer UK Clinical Pioneer Awards

The Clinical Pioneers Award scheme is an opportunity for clinicians and non-clinicians (for example qualitative research academics or technology developers) who have innovative project ideas that are focused on interventions within the clinical or community setting to improve diagnosis, treatment and care, quality of life or experience for pancreatic cancer patients or carers to receive funding. It responds to the fact that these types of projects might find it difficult to receive funding through existing funding streams and is hoped that these interventions will have an impact on patient outcomes.

Clinical Pioneer Awards 2019/20 – call opening soon

With the success of our previous awards, we are pleased to announce that we will be launching a new call for a Clinical Pioneer Awards to be awarded in 2020.

The detailed guidance of the application and award process and key deadlines will be made available when the award opens in Summer 2019. Below is some general pre-launch information and guidance, that we hope will inform those considering applying.


Funding is awarded to projects that address one of five key priority areas, as identified by people affected by pancreatic cancer. Applicants are asked to demonstrate how their application would target one of these areas:

  • Awareness raising
  • Early and rapid diagnosis
  • Promoting quality of life
  • Treatment and survival
  • Supportive care needs (2018 Patient Survey findings)


Projects should be hosted within an NHS organisation, university or recognised not-for-profit research institution.


Funding will be awarded to a team led by one Lead applicant, with broad and appropriate expertise and a strong track record in engaging with key stakeholders, and testing and applying interventions in practice.


In 2019/20 at total of £200,000 is available. Funding will be awarded to a maximum of 4 awards.

For each award, a total of up to £50,000 is available to support directly incurred research costs for up to 12 months, such as:

  • Staff salaries
  • Consumables
  • Equipment
  • Travel costs
  • Costs to support patient involvement


Up to 12 months

All applications for funding are subject to a rigorous review process to identify proposals with the best chances of making a difference to people affected by pancreatic cancer. A final funding recommendation is made by our Medical Advisory Board (MAB).

Pancreatic Cancer UK’s 2018 Patient Survey

In 2018, we commissioned Oxford Brookes University and the Picker Institute to undertake a Patient Survey, measuring the experience and supportive care needs for people with pancreatic cancer. This is the first time in the UK, we are able to understand these needs for people living with and beyond pancreatic cancer and is imperative for people with the disease who are often diagnosed late and experience severe symptoms affecting their wellbeing and survival.

We strongly encourage those considering applying for this award to read and consider the findings of this survey when developing their proposal. Tackling the issues raised by people with experience of pancreatic cancer is priority to the Charity and as such be the sole focus of these awards.

A summary and detailed breakdown of the findings can be found on our Patient Survey webpages.

Key dates (provisional until formal announcement):

Round Open Date

MAB meeting


Projects start date

July/August 2019 (open until October/November 2019)

February/March 2020

March 2020

June/July 2020


For any queries relating to this fund, please email or call the research team on 020 7820 6705

Details of the previous 2016 Future Leader Academy provided below for reference.